Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medinotec (MDNC) EPS (Basic) (2022 - 2025)

Medinotec filings provide 4 years of EPS (Basic) readings, the most recent being $0.03 for Q4 2025.

  • On a quarterly basis, EPS (Basic) changed 0.0% to $0.03 in Q4 2025 year-over-year; TTM through Nov 2025 was $0.19, a 171.43% increase, with the full-year FY2025 number at $0.18, up 700.0% from a year prior.
  • EPS (Basic) hit $0.03 in Q4 2025 for Medinotec, roughly flat from $0.03 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.12 in Q1 2025 to a low of -$0.04 in Q4 2023.
  • Median EPS (Basic) over the past 4 years was $0.01 (2022), compared with a mean of $0.01.
  • Biggest five-year swings in EPS (Basic): plummeted 400.0% in 2023 and later soared 1100.0% in 2025.
  • Medinotec's EPS (Basic) stood at $0.02 in 2022, then plummeted by 300.0% to -$0.04 in 2023, then soared by 175.0% to $0.03 in 2024, then changed by 0.0% to $0.03 in 2025.
  • The last three reported values for EPS (Basic) were $0.03 (Q4 2025), $0.03 (Q3 2025), and $0.01 (Q2 2025) per Business Quant data.